Identifying immune infiltration pattern of PD-L1 positive and negative lung adenocarcinoma

被引：0
|
作者：
Heidel, C. [1 ,2 ]
Jokic, M. [1 ,2 ]
Faehnrich, A. [3 ]
Kuempers, C. [1 ,2 ]
Vogel, W. [1 ,2 ]
Vlasic, I. [1 ,2 ]
Kirfel, J. [1 ,2 ]
Busch, H. [3 ]
Perner, S. [1 ,2 ]
机构：
[1] Univ Hosp Schleswig Holstein, Inst Pathol, Campus Luebeck, Lubeck, Germany
[2] Leibniz Lung Ctr, Res Ctr Borstel, Pathol, Borstel, Germany
[3] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P407
引用
下载
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [41] CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma
    Shang, Xiaoling
    Li, Jia
    Wang, Hui
    Li, Zhenxiang
    Lin, Jiamao
    Chen, Dawei
    Wang, Haiyong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [42] About PD-L1 Immunohistochemistry and RNA In Situ Hybridization in Lung Adenocarcinoma
    Uguen, Arnaud
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (01) : E9 - E10
  • [43] PD-L1 Expression and Its Regulation in Lung Adenocarcinoma with ALK Translocation
    Ma, Li
    Lv, Jialin
    Dong, Yujie
    Zhang, Xinyong
    Li, Xi
    Zhang, Hui
    Nong, Jingying
    Zhang, Quan
    Qin, Na
    Yang, Xinjie
    Wang, Jinghui
    Zhang, Shucai
    INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2019, 11 (02) : 266 - 272
  • [44] Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma
    Falk, A.
    Yazbeck, N.
    Thon, L.
    Hofman, V.
    Zahaf, K.
    Washetine, K.
    Cohen, C.
    Marquette, C. H.
    Brest, P.
    Llie, M.
    Holman, P.
    VIRCHOWS ARCHIV, 2016, 469 : S40 - S40
  • [45] Positive association between macrophage infiltration and PD-L1 expression in the tumor microenvironment
    Cumberbatch, M.
    Memeo, L.
    Bhagat, M.
    Womack, C.
    Kim, W. H.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S62 - S62
  • [46] Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma
    Ilie, Marius
    Fazzalari, Laetitia
    Guibert, Nicolas
    Yazbeck., Nathalie
    Signetti, Laurie
    Hofman, Veronique
    Long, Elodie
    Zahaf, Katia
    Fayada, Julien
    Lespinet, Virginie
    Bordone, Olivier
    Tanga, Virginie
    Washetine, Kevin
    Venissac, Nicolas
    Mouroux, Jerome
    Marquette, Charles Hugo
    Brest, Patrick
    Hofnnan, Paul
    CANCER RESEARCH, 2016, 76
  • [47] PD-L1 mRNA expression in EGFR-mutant lung adenocarcinoma
    Isobe, Kazutoshi
    Kakimoto, Atsushi
    Mikami, Tetuo
    Kaburaki, Kyohei
    Kobayashi, Hiroshi
    Yoshizawa, Takahiro
    Nakano, Yuta
    Makino, Takashi
    Otsuka, Hajime
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Tochigi, Naobumi
    Iyoda, Akira
    Homma, Sakae
    ONCOLOGY REPORTS, 2018, 40 (01) : 331 - 338
  • [48] PD-L1 expression in squamous-cell carcinoma and adenocarcinoma of the lung
    Janzic, Urska
    Kern, Izidor
    Janzic, Andrej
    Cavka, Luka
    Cufer, Tanja
    RADIOLOGY AND ONCOLOGY, 2017, 51 (03) : 357 - 362
  • [49] PD-L1 Expression and Its Regulation in Lung Adenocarcinoma with ALK Translocation
    Li Ma
    Jialin Lv
    Yujie Dong
    Xinyong Zhang
    Xi Li
    Hui Zhang
    Jingying Nong
    Quan Zhang
    Na Qin
    Xinjie Yang
    Jinghui Wang
    Shucai Zhang
    Interdisciplinary Sciences: Computational Life Sciences, 2019, 11 : 266 - 272
  • [50] PD-L1 expression according to the EGFR status in primary lung adenocarcinoma
    Takada, Kazuki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Kohashi, Kenichi
    Shimokawa, Mototsugu
    Akamine, Takaki
    Takamori, Shinkichi
    Hirai, Fumihiko
    Shoji, Fumihiro
    Okamoto, Tatsuro
    Oda, Yoshinao
    Maehara, Yoshihiko
    LUNG CANCER, 2018, 116 : 1 - 6
12345